A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)

PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) - Pfizer

13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i) - Sinovac, CanSino

http://clinicaltrials.gov/ct2/show/NCT07017777

Aug 6, 2026